China National Pharmaceutical Group Corporation: Net profit in 2025 is 1.997 billion yuan, a year-on-year decrease of 0.18%.

Guoyao Group announced that its operating income in 2025 was 52.468 billion yuan, an increase of 3.70% year-on-year. Net profit was 1.997 billion yuan, a decrease of 0.18% year-on-year. The company plans to use the total share capital of 755 million shares on December 31, 2025 as the base, and distribute a cash dividend of 8 yuan per 10 shares, totaling 604 million yuan in cash dividends.